Page last updated: 2024-12-05
dibutoline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
dibutoline: RN given refers to parent cpd; structure in Negwer, 5th ed, #2941 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10764 |
| CHEMBL ID | 2110746 |
| MeSH ID | M0050456 |
Synonyms (16)
| Synonym |
|---|
| dibutoline |
| dibuline |
| 2-(dibutylcarbamoyloxy)ethyl-ethyl-dimethylazanium |
| 2-(((dibutylamino)carbonyl)oxy)-n-ethyl-n,n-dimethylethanaminium |
| ammonium, ethyl(2-hydroxyethyl)dimethyl-, dibutylcarbamate (ester) |
| (ethyl(2-hydroxyethyl)dimethylammonium)sulfate bis(dibutylcarbamate) |
| ethanaminium, 2-(((dibutylamino)carbonyl)oxy)-n-ethyl-n,n-dimethyl- |
| 21962-82-3 |
| unii-1b3q705aqh |
| 1b3q705aqh , |
| dibutoline cation |
| dibutoline ion |
| CHEMBL2110746 |
| DTXSID90176369 |
| 3-(cyclopropylaminocarbonyl)phenylboronicacid |
| Q27252181 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 13 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||